ÇѸ²´ëÇб³¼º½Éº´¿ø

¼­ÇöÁö ±³¼ö

hjseo@hallym.or.kr
  • Áø·á°ú °¨¿°³»°ú

Àü¹®Áø·áºÐ¾ß

°¨¿°Áúȯ, ¸é¿ªÀúÇÏÀÚ°¨¿°, ¿¹¹æÁ¢Á¾

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2024-12-02 ~ 2024-12-07)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü
¿ÀÈÄ ¿Ü·¡Áø·á¿Ü·¡Áø·á
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

2021.03¿ï»ê´ëÇб³ ´ëÇпø ¹Ú»ç

2018.03 ~ 2020.02¿ï»ê´ëÇб³ ´ëÇпø ¼®»ç

2009.03 ~ 2015.02°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ Çлç

°æ·Â

°æ·Â

2023.03 ~ ÇѸ²´ëÇб³ ¼º½Éº´¿ø ÀÓ»óÁ¶±³¼ö

2022.03 ~ 2023.02ÇѸ²´ëÇб³ ¼º½Éº´¿ø ÀÓ»ó°­»ç

2020.03 ~ 2022.02¼­¿ï¾Æ»êº´¿ø °¨¿°³»°ú ÀÓ»ó°­»ç

2019.09 ~ 2019.09¹Ì±¹ NewYork-Presbyterian Hospital °¨¿°³»°ú ¿¬¼ö

2016.03 ~ 2020.02¼­¿ï¾Æ»êº´¿ø ³»°ú Àü°øÀÇ

2015.02 ~ 2016.02¼­¿ï¾Æ»êº´¿ø ÀÎÅÏ

ÇÐȸȰµ¿

ÇÐȸȰµ¿

´ëÇѳ»°úÇÐȸ Á¤È¸¿ø

´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ Á¤È¸¿ø

´ëÇÑ°¨¿°ÇÐȸ Á¤È¸¿ø

´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ Á¤È¸¿ø

³í¹®

1) Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia (International Journal of Antimicrobial Agents)

2) Comparison of clinical outcomes of patients infected with KPC- and NDM-producing Enterobacterales: a retrospective cohort study (Clinical Microbiology and Infection)

3) Diagnostic performance of real-time polymerase chain reaction assay on blood for invasive aspergillosis and mucormycosis (Mycoses)

4) Risk Factors for Mortality in Patients with Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae and Escherichia coli bacteremia (Infection & Chemotherapy)

5) Radiologically Suspected Organizing Pneumonia in a Patient Recovering from COVID-19: A Case Report (Infection & Chemotherapy)

6) Comparison of the Clinical Outcomes of Patients With Positive Xpert Carba-R Tests for Carbapenemase-Producing Enterobacterales According to Culture Positivity (Open Forum Infectious Diseases)